Found: 68
Select item for more details and to access through your institution.
Results from a retrospective case finding and re-engagement exercise for people previously diagnosed with hepatitis C virus to increase uptake of directly acting antiviral treatment.
- Published in:
- BMC Public Health, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12889-024-19919-3
- By:
- Publication type:
- Article
THE USE OF CT SCANNING IN DEMENTIAA Systematic Review.
- Published in:
- International Journal of Technology Assessment in Health Care, 1999, v. 15, n. 2, p. N.PAG, doi. 10.1017/s0266462399152115
- By:
- Publication type:
- Article
Endothelin-1 as a mediator and potential biomarker for interferon induced pulmonary toxicity.
- Published in:
- Pulmonary Circulation, 2012, v. 2, n. 4, p. 501, doi. 10.4103/2045-8932.105039
- By:
- Publication type:
- Article
Safety and efficacy of glecaprevir/pibrentasvir for the treatment of chronic hepatitis C in patients aged 65 years or older.
- Published in:
- PLoS ONE, 2019, v. 14, n. 01, p. 1, doi. 10.1371/journal.pone.0208506
- By:
- Publication type:
- Article
Influencing Factors on the Outcome and Prognosis of Patients With HBV Infection: Seven Years Follow-up.
- Published in:
- Hepatitis Monthly, 2013, v. 13, n. 7, p. 1, doi. 10.5812/hepatmon.8743
- By:
- Publication type:
- Article
Efficacy and safety of telaprevir in patients with genotype 1 hepatitis C infection.
- Published in:
- Therapeutic Advances in Gastroenterology, 2012, v. 5, n. 2, p. 139, doi. 10.1177/1756283X11426895
- By:
- Publication type:
- Article
Ethnicity and the diagnosis gap in liver disease: a population-based study.
- Published in:
- British Journal of General Practice, 2014, v. 64, n. 628, p. e694, doi. 10.3399/bjgp14X682273
- By:
- Publication type:
- Article
Editorial.
- Published in:
- 2004
- By:
- Publication type:
- Editorial
Injecting drug users with chronic hepatitis C: should they be offered antiviral therapy?
- Published in:
- 2008
- By:
- Publication type:
- Editorial
Efficacy and Safety of Sofosbuvir/Velpatasvir in Patients With Chronic Hepatitis C Virus Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3 ASTRAL Trials.
- Published in:
- Clinical Infectious Diseases, 2016, v. 63, n. 11, p. 1479, doi. 10.1093/cid/ciw579
- By:
- Publication type:
- Article
Ribavirin-Free RegimenWith Sofosbuvir and Velpatasvir Is Associated With High Efficacy and Improvement of Patient-Reported Outcomes in Patients With Genotypes 2 and 3 Chronic Hepatitis C: Results From Astral-2 and -3 Clinical Trials.
- Published in:
- Clinical Infectious Diseases, 2016, v. 63, n. 8, p. 1042, doi. 10.1093/cid/ciw496
- By:
- Publication type:
- Article
Interferon Alpha Induces Sustained Changes in NK Cell Responsiveness to Hepatitis B Viral Load Suppression In Vivo.
- Published in:
- PLoS Pathogens, 2016, v. 12, n. 8, p. 1, doi. 10.1371/journal.ppat.1005788
- By:
- Publication type:
- Article
Sofosbuvir/velpatasvir in patients with hepatitis C virus genotypes 1‐6 and compensated cirrhosis or advanced fibrosis.
- Published in:
- Liver International, 2018, v. 38, n. 3, p. 443, doi. 10.1111/liv.13534
- By:
- Publication type:
- Article
Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin in Patients With Chronic Hepatitis C Virus Genotype 1 Infection Receiving Opioid Substitution Therapy: A Post Hoc Analysis of 12 Clinical Trials.
- Published in:
- Open Forum Infectious Diseases, 2018, v. 5, n. 11, p. N.PAG, doi. 10.1093/ofid/ofy248
- By:
- Publication type:
- Article
Pegylated Interferons for the Treatment of Chronic Hepatitis C: Pharmacological and Clinical Differences between Peginterferon-α-2a and Peginterferon-α-2b.
- Published in:
- Drugs, 2010, v. 70, n. 2, p. 147, doi. 10.2165/11531990-000000000-00000
- By:
- Publication type:
- Article
Seroprevalence and demographic factors associated with hepatitis B, hepatitis C and HIV infection from a hospital emergency department testing programme, London, United Kingdom, 2015 to 2016.
- Published in:
- Eurosurveillance (15607917), 2019, v. 24, n. 27, p. 1, doi. 10.2807/1560-7917.ES.2019.24.27.1800377
- By:
- Publication type:
- Article
HepFREEPak: protocol for a multi-centre, prospective observational study examining efficacy and impact of current therapies for the treatment of hepatitis C in Pakistan and reporting resistance to antiviral drugs: study protocol.
- Published in:
- BMC Public Health, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12889-023-17290-3
- By:
- Publication type:
- Article
The complex, confusing and poorly understood immune responses to AAV‐mediated gene transfer in haemophilia—Is more or less immunosuppression required?
- Published in:
- Journal of Viral Hepatitis, 2024, v. 31, p. 21, doi. 10.1111/jvh.13934
- By:
- Publication type:
- Article
Hepatitis after gene therapy, what are the possible causes?
- Published in:
- Journal of Viral Hepatitis, 2024, v. 31, p. 14, doi. 10.1111/jvh.13919
- By:
- Publication type:
- Article
The tolerability of sofosbuvir/velpatasvir for 12 weeks in patients treated in the ASTRAL 1, 2 and 3 studies: A pooled safety analysis.
- Published in:
- Journal of Viral Hepatitis, 2023, v. 30, n. 5, p. 448, doi. 10.1111/jvh.13814
- By:
- Publication type:
- Article
Determining the lower limit of detection required for HCV viral load assay for test of cure following direct‐acting antiviral‐based treatment regimens: Evidence from a global data set.
- Published in:
- Journal of Viral Hepatitis, 2022, v. 29, n. 6, p. 474, doi. 10.1111/jvh.13672
- By:
- Publication type:
- Article
Role of peer support in a hepatitis C elimination programme.
- Published in:
- Journal of Viral Hepatitis, 2022, v. 29, n. 1, p. 43, doi. 10.1111/jvh.13626
- By:
- Publication type:
- Article
Efficacy and safety of a two‐drug direct‐acting antiviral agent regimen ruzasvir 180 mg and uprifosbuvir 450 mg for 12 weeks in adults with chronic hepatitis C virus genotype 1, 2, 3, 4, 5 or 6.
- Published in:
- Journal of Viral Hepatitis, 2019, v. 26, n. 9, p. 1127, doi. 10.1111/jvh.13132
- By:
- Publication type:
- Article
Genetic variation in FCER1A predicts peginterferon alfa‐2a‐induced hepatitis B surface antigen clearance in East Asian patients with chronic hepatitis B.
- Published in:
- Journal of Viral Hepatitis, 2019, v. 26, n. 9, p. 1040, doi. 10.1111/jvh.13107
- By:
- Publication type:
- Article
The Journal Of Viral Hepatitis 2016.
- Published in:
- 2016
- By:
- Publication type:
- Editorial
English hepatitis C registry data show high response rates to directly acting anti‐virals, even if treatment is not completed.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 1, p. 168, doi. 10.1111/apt.15780
- By:
- Publication type:
- Article
The association between hepatocellular carcinoma and direct‐acting anti‐viral treatment in patients with decompensated cirrhosis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 2, p. 204, doi. 10.1111/apt.15296
- By:
- Publication type:
- Article
Viral genome wide association study identifies novel hepatitis C virus polymorphisms associated with sofosbuvir treatment failure.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-25649-6
- By:
- Publication type:
- Article
Hepatitis C prevalence in England remains low and varies by ethnicity: an updated evidence synthesis.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Hepatitis C prevalence in England remains low and varies by ethnicity: an updated evidence synthesis.
- Published in:
- European Journal of Public Health, 2012, v. 22, n. 2, p. 187, doi. 10.1093/eurpub/ckr083
- By:
- Publication type:
- Article
Stat2 loss disrupts damage signalling and is protective in acute pancreatitis.
- Published in:
- Journal of Pathology, 2020, v. 252, n. 1, p. 41, doi. 10.1002/path.5481
- By:
- Publication type:
- Article
Characteristics, Diagnosis and Prognosis of Acute-on-Chronic Liver Failure in Cirrhosis Associated to Hepatitis B.
- Published in:
- Scientific Reports, 2016, p. 25487, doi. 10.1038/srep25487
- By:
- Publication type:
- Article
Hepatitis B virus-specific T cells associate with viral control upon nucleos(t)ide-analogue therapy discontinuation.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Targeted vs opportunistic screening for viral hepatitis among UK migrant communities: a cost-effectiveness analysis.
- Published in:
- British Journal of Healthcare Management, 2021, v. 27, n. 3, p. 90, doi. 10.12968/bjhc.2020.0077
- By:
- Publication type:
- Article
Insulin resistance is independently associated with significant hepatic fibrosis in Asian chronic hepatitis C genotype 2 or 3 patients.
- Published in:
- Journal of Gastroenterology & Hepatology, 2011, v. 26, n. 7, p. 1182, doi. 10.1111/j.1440-1746.2011.06722.x
- By:
- Publication type:
- Article
Efficacy of a 12-Week Simeprevir Plus Peginterferon/Ribavirin (PR) Regimen in Treatment-Naïve Patients with Hepatitis C Virus (HCV) Genotype 4 (GT4) Infection and Mild-To-Moderate Fibrosis Displaying Early On-Treatment Virologic Response.
- Published in:
- PLoS ONE, 2017, v. 12, n. 1, p. 1, doi. 10.1371/journal.pone.0168713
- By:
- Publication type:
- Article
Qualitatively distinct patterns of cytokines are released by human dendritic cells in response to different pathogens.
- Published in:
- Immunology, 2005, v. 116, n. 2, p. 245, doi. 10.1111/j.1365-2567.2005.02218.x
- By:
- Publication type:
- Article
Rifaximin Reduces Markers of Inflammation and Bacterial 16S rRNA in Zambian Adults with Hepatosplenic Schistosomiasis: A Randomized Control Trial.
- Published in:
- American Journal of Tropical Medicine & Hygiene, 2018, v. 98, n. 4, p. 1152, doi. 10.4269/ajtmh.17-0637
- By:
- Publication type:
- Article
Informing the design of a national screening and treatment programme for chronic viral hepatitis in primary care: qualitative study of at-risk immigrant communities and healthcare professionals.
- Published in:
- BMC Health Services Research, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12913-015-0746-y
- By:
- Publication type:
- Article
Human T cells elicit IFN-α secretion from dendritic cells following cell to cell interactions.
- Published in:
- European Journal of Immunology, 2000, v. 30, n. 11, p. 3228, doi. 10.1002/1521-4141(200011)30:11<3228::AID-IMMU3228>3.0.CO;2-B
- By:
- Publication type:
- Article
Efficacy and safety profile of boceprevir- or telaprevir-based triple therapy or dual peginterferon alfa-2a or alfa-2b plus ribavirin therapy in chronic hepatitis C: the real-world PegBase observational study.
- Published in:
- Annals of Gastroenterology, 2017, v. 30, n. 3, p. 327, doi. 10.20524/aog.2017.0136
- By:
- Publication type:
- Article
Final analysis of the international observational S-Collate study of peginterferon alfa-2a in patients with chronic hepatitis B.
- Published in:
- PLoS ONE, 2020, v. 15, n. 4, p. 1, doi. 10.1371/journal.pone.0230893
- By:
- Publication type:
- Article
Faldaprevir, pegylated interferon, and ribavirin for treatment-naïve HCV genotype-1: pooled analysis of two phase 3 trials.
- Published in:
- Annals of Hepatology: Official Journal of the Mexican Association of Hepatology, 2016, v. 15, n. 3, p. 333, doi. 10.5604/16652681.1198803
- By:
- Publication type:
- Article
Diagnosis and treatment of chronic hepatitis B.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Diagnosis and treatment of chronic hepatitis B.
- Published in:
- Journal of the Royal Society of Medicine, 2004, v. 97, n. 7, p. 318, doi. 10.1177/014107680409700703
- By:
- Publication type:
- Article
Diagnosis and treatment of hepatitis C.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Diagnosis and treatment of hepatitis C.
- Published in:
- Journal of the Royal Society of Medicine, 2004, v. 97, n. 5, p. 223, doi. 10.1177/014107680409700504
- By:
- Publication type:
- Article
Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Hepatosplenic schistosomiasis is characterised by high blood markers of translocation, inflammation and fibrosis.
- Published in:
- Liver International, 2016, v. 36, n. 1, p. 145, doi. 10.1111/liv.12891
- By:
- Publication type:
- Article
Low-density lipoprotein and other predictors of response with telaprevir-based therapy in treatment-experienced HCV genotype 1 patients: REALIZE study.
- Published in:
- Liver International, 2015, v. 35, n. 2, p. 448, doi. 10.1111/liv.12703
- By:
- Publication type:
- Article